External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience MDA 2025
Roche and Genentech at

MDA 2025

March 16 - March 19
Dallas, TX
mdaconference.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
11:00 PM
Duration 120mins Dallas, TX
Assessing biomarkers of bone metabolism and the role of the IL-6 signalling pathway in patients with Duchenne Muscular Dystrophy
M Guridi, C De Ford, C Fruechtenicht, C Gee See, R Houghton, Y Chen, AP Murphy, C Wood, L Ward, N Crabtree, EM Mercuri, H McMillan
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Dallas, TX
Natural history of bone health in Duchenne Muscular Dystrophy: A systematic review and implications for the design of a clinical trial
C De Ford, M Guridi, Y Chen, A P. Murphy, C Wood, H McMillan, E M. Mercuri, N Crabtree, L Ward
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Dallas, TX
Impact of satralizumab▼ on bone strength and muscle function in Duchenne muscular dystrophy (DMD): design of the SHIELD-DMD study
Proud CM, De Ford C, Guridi M, Estevez-Fraga C, Peck R, Lennon-Chrimes S, Blondeau K, Craggs C, Machado V, Veerapandiyan A, Kostera-Pruszczyk A, Nascimento A, Ward LM, Mercuri E
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Dallas, TX
Real-world risdiplam▼ effectiveness in adults with spinal muscular atrophy (SMA) from the Pediatric Neuromuscular Clinical Research (PNCR) registry
D Jayaraman, S Roumpanis, W Martens, T Dickendesher, S Shapouri, B Darras, RS Finkel, M Hirano, Z Zolkipli-Cunningham, A Gershon, on behalf of the PNCR network
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 120mins Dallas, TX
SUNFISH Parts 1 and 2: 5-year efficacy and safety data of risdiplam▼ in Types 2 and 3 spinal muscular atrophy (SMA)
L Servais, JW Day, N Deconinck, E Mazzone, A Nascimento, M Oskoui, K Saito, C Vuillerot, G Baranello, O Boespflug-Tanguy, N Goemans, J Kirschner, A Kostera-Pruszczyk, K Sully, M Kuthiala, K Gorni, C Martin, WY Yeung, R Scalco, E Mercuri, on behalf of the SUNFISH Study Group
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 121mins Dallas, TX
Muscle MRI outcomes in patients with Duchenne Muscular Dystrophy treated with delandistrogene moxeparvovec: Findings from EMBARK Part 1
K Vandenborne, G Walter, V Straub, R Willcocks, S Forbes, S Ennamuri, K Ding, C Reid, A Murphy, M Manfrini, J Elkins, L Rodino-Klapac4
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 121mins Dallas, TX
Long-term functional outcomes, safety, and micro-dystrophin expression following delandistrogene moxeparvovec treatment in DMD: EMBARK 2-year results
J R. Mendell, F Muntoni, C M. McDonald, E M. Mercuri, E Ciafaloni, H Komaki, C Leon-Astudillo, A Nascimento, C Proud, U Schara-Schmidt, A Veerapandiyan, C M. Zaidman, M Furgerson, K Ding, P Singh, R Potter, D R. Asher, A P. Murphy, C Reid, G Hooper, C O. Torre, M Manfrini, J S. Elkins, L R. Rodino-Klapac, on behalf of the EMBARK Study Group
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 121mins Dallas, TX
3-Year Functional Outcomes of Patients With Duchenne Muscular Dystrophy: Pooled Delandistrogene Moxeparvovec Clinical Trial Data vs External Controls
Jerry Mendell, Anne M. Connolly, John Day, Craig McDonald, Crystal Proud, Perry Shieh, Craig Zaidman, Matthew Furgerson, Kai Ding, Carol Reid, Alexander P. Murphy, Jacob S. Elkins, Louise Rodino-Klapac
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 121mins Dallas, TX
Assessment of Cardiac Outcomes in Delandistrogene Moxeparvovec Clinical Trials for Duchenne Muscular Dystrophy
Aravindhan Veerapandiyan, John Bourke, John Day, Craig McDonald, Jerry Mendell, Jonathan Soslow, Craig Zaidman, Stefanie Mason, Jianfeng Meng, Mark Vivien, Tao Niu, Alexander P. Murphy, Christoph Wandel, James Richardson
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 121mins Dallas, TX
Long-Term Safety and Tolerability of Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy: Phase 1 to Phase 3 Clinical Trials
Jerry Mendell, Craig McDonald, Eugenio Mercuri, Francesco Muntoni, Craig Zaidman, Sachi Dharia, Stefanie Mason, Jianfeng Meng, Alexander P. Murphy, Emanuel Palatinsky, Carol Reid, Christoph Wandel, Crystal Proud
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 121mins Dallas, TX
Longitudinal Stride-Level Evaluation of Ambulatory Function with Ankle Wearable Technology in Ambulant DMD Patients Below 4 Years Old
Laurent Servais, Margaux Poleur, Guillaume Parinello, Eva Vrščaj, Camille Bisson, Céline Cluzeau, Aurore Daron, Lena Szabo, Damjan Osredkar, Paul Strijbos, Damien Eggenspieler
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:15 PM
Duration 15mins Hilton Anatole
Long-Term Functional Outcomes and Safety of Delandistrogene Moxeparvovec in DMD: EMBARK 2-Year and Pooled 3-Year Analyses
C Proud, J R. Mendell, F Muntoni, C M. McDonald, E M. Mercuri, E Ciafaloni, H Komaki, C Leon-Astudillo, A Nascimento, C Proud, U Schara-Schmidt, A Veerapandiyan, C M. Zaidman, M Furgerson, K Ding, P Singh, R Potter, D R. Asher, A P. Murphy, C Reid, G Hooper, C O. Torre, M Manfrini, J S. Elkins, L R. Rodino-Klapac, on behalf of the EMBARK Study Group
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
02:30 PM
Duration 15mins Hilton Anatole
Muscle MRI outcomes in patients with Duchenne Muscular Dystrophy treated with delandistrogene moxeparvovec: Findings from EMBARK Part 1
K Vandenborne, G Walter, V Straub, R Willcocks, S Forbes, S Ennamuri, K Ding, C Reid, A Murphy, M Manfrini, J Elkins, L Rodino-Klapac4
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:00 PM
Duration 15mins Hilton Anatole
RAINBOWFISH: 2-year efficacy and safety data of risdiplam▼ in infants with presymptomatic spinal muscular atrophy (SMA)
RS Finkel, MA Farrar, L Servais, D Vlodavets, E Zanoteli, M Al-Muhaizea, APQC Araujo, L Nelson, B Jaber, K Gorni, H Kletzl, L Palfreeman, E Gaki, M Rabbia, D Summers, P Fontoura, E Bertini
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.